Fred Howard
@fredhow
Breast Medical Oncologist @UCCancerCenter | Former chief resident @YaleIMed | Using big data and AI to answer clinical questions in breast cancer care
ID: 26129409
24-03-2009 00:12:48
89 Tweet
274 Followers
216 Following
Excited to share our study of RSClin in 280k pts doi.org/10.1002/cncr.3… In the lowest risk pts per RSClin-no chemo benefit even if Oncotype high. For high risk-question of OFS vs chemo remains (I vote OFS) Congrats Augustin! Genomic Health® Olufunmilayo Olopade Rita Nanda UChicago Medicine Breast Cancer Program